PNCK Antibody (C-term R331) Blocking Peptide

Catalog Number: ABT-BP7097B
Article Name: PNCK Antibody (C-term R331) Blocking Peptide
Biozol Catalog Number: ABT-BP7097B
Supplier Catalog Number: BP7097b
Alternative Catalog Number: ABT-BP7097B-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Calcium/calmodulin-dependent protein kinase type 1B, CaM kinase I beta, CaM kinase IB, CaM-KI beta, CaMKI-beta, Pregnancy up-regulated non-ubiquitously-expressed CaM kinase, PNCK
Calcium/calmodulin-dependent protein kinase (PNCK) belongs to a proposed calcium-triggered signaling cascade. In vitro it phosphorylates CREB1 and SYN1/synapsin I, and phosphorylates and activates CAMK1.Protein kinases are enzymes that transfer a phosphate group from a phosphate donor, generally the g phosphate of ATP, onto an acceptor amino acid in a substrate protein. By this basic mechanism, protein kinases mediate most of the signal transduction in eukaryotic cells, regulating cellular metabolism, transcription, cell cycle progression, cytoskeletal rearrangement and cell movement, apoptosis, and differentiation. With more than 500 gene products, the protein kinase family is one of the largest families of proteins in eukaryotes. The family has been classified in 8 major groups based on sequence comparison of their tyrosine (PTK) or serine/threonine (STK) kinase catalytic domains.
NCBI: 139728
UniProt: Q6P2M8
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP7097b was selected from the C-term region of human PNCK. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.